Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2008.12.071PMID 19515505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral PresentationParotid Gland Function after Radiotherapy: The Combined Michigan and Utrecht Experience

  2008cited by this paper
• What do recent studies on lumpectomy cavity volume change imply for breast clinical target volumes?

  2008cited by this paper
• Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.

  2008cited by this paper
• Parotid gland function after radiotherapy: the combined michigan and utrecht experience.

  2008cited by this paper
• Lyman–Kutcher–Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data

  2008cited by this paper
• Adjuvant therapy in patients with resected poor-risk head and neck cancer.

  2006cited by this paper
• Distribution and roles of aquaporins in salivary glands.

  2006cited by this paper
• Etablierung einer 3D-Konformationstechnik zur Radio therapie von Kopf-Hals-Tumoren unter Berücksichtigung der Parotisschonung

  2006cited by this paper
• [Presentation of a 3D conformal radiotherapy technique for head-and-neck tumors resulting in substantial protection of the parotid glands].

  2006cited by this paper
• Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.

  2005cited by this paper
• Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.

  2005cited by this paper
• Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands.

  2005cited by this paper
• Dose and volume impact on radiation-induced xerostomia.

  2005cited by this paper
• Volume effects and region-dependent radiosensitivity of the parotid gland.

  2005cited by this paper
• Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.

  2004cited by this paper
• Protective effects of EGCG on salivary gland cells treated with gamma-radiation or cis-platinum(II)diammine dichloride.

  2004cited by this paper
• Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

  2004cited by this paper
• Xerostomia and hypofunction of the salivary glands in cancer therapy

  2003cited by this paper
• Drug effects on salivary glands: dry mouth.

  2003cited by this paper
• Cisplatin and Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer

  2003cited by this paper
• Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.

  2003cited by this paper
• Secretion of Saliva in X-Irradiated Rat Submandibular Glands

  2003cited by this paper
• The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature.

  2002cited by this paper
• A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.

  2001cited by this paper
• Cisplatin decreases the abundance of aquaporin water channels in rat kidney.

  2001cited by this paper
• Qantitative dose-volume response analysis of changes in parotid gland function after radiotheraphy in the head-and-neck region

  2001cited by this paper
• Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region.

  2001cited by this paper
• The buffer capacity and buffer systems of human whole saliva measured without loss of CO2.

  2000cited by this paper
• Assessment of salivary gland dysfunction following chemoradiotherapy using quantitative salivary gland scintigraphy.

  1999cited by this paper
• Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study.

  1998cited by this paper
• Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer.

  1997cited by this paper
• Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment.

  1990cited by this paper
• Complication Probability as Assessed from Dose-Volume Histograms

  1985cited by this paper
• Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study.

  1981cited by this paper

• Chemosensory response to Pt-based chemotherapeutics via bitter taste receptors in vitro reveals a new mechanism for bitter taste disorders

  2026cites this paper
• Parotid preservation or immune protection? The dual dilemma in head and neck cancer radiotherapy

  2025cites this paper
• The spectrum of late radiation sequelae in head and neck cancer.

  2024cites this paper
• CISPLATIN INDUCED INJURY ON RAT SUBMANDIBULAR SALIVARY GLAND (HISTOLOGICAL AND ULTRASTRUCTURAL EVALUATION)

  2024cites this paper
• Reduced Salivary Flow Rate and Increased Caries Susceptibility in Italian Children in Remission from Hematological Malignancy

  2023cites this paper
• Effects of chemo-therapeutic drugs used in head and neck cancers on sub-mandibular glands of rats

  2022cites this paper
• The possible protective effect of Graviola extract on salivary gland against cytotoxicity during cisplatin treatment (Histological, Biochemical and Immuno-histochemical Study)

  2021cites this paper
• Protective role of royal jelly to alleviate side effects of chemotherapy on submandibular salivary glands of albino rats (Histological and Electron Microscopic Study)

  2021cites this paper
• Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial

  2021cites this paper
• A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era

  2021cites this paper
• Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy

  2021influential citation
• [Concurrent chemoradiotherapy for head neck cancers. Should organs at risk dose constraints be revisited ?]

  2020cites this paper
• Potential benefit of Annona muricata extract in combating cisplatin induced injury of parotid gland in albino rats

  2020cites this paper
• An Update on Drug-induced Oral Reactions.

  2018cites this paper
• Radiotherapy in the Region of the Head and Neck and the Consequential Changes in Normal Tissues

  2018cites this paper
• Radiotherapy in the Region of the Head and Neck and the Consequential Changes in Normal Tissues

  2018cites this paper
• A study on Evaluation of efficacy of bethanechol in the management of chemoradiation-induced xerostomia in oral cancer patients

  2017cites this paper
• ROLE OF GHRELIN ON CISPLATIN INDUCED MORPHOLOGICAL CHANGES ON SUBMANDIBULAR SALIVARY GLANDS

  2017cites this paper
• The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines.

  2017cites this paper
• Treatment of late sequelae after radiotherapy for head and neck cancer.

  2017cites this paper
• The Effect of Different Routes of Injection of Bone Marrow Mesenchymal Stem Cells on Parotid Glands of Rats Receiving Cisplatin: A Comparative Study

  2017cites this paper
• Survival and quality of life in oropharyngeal cancer patients treated with primary chemoradiation after salivary gland transfer

  2016cites this paper
• Superficial oral mucoceles in cancer patient after radiation therapy: An overlooked yet imperative phenomenon.

  2016cites this paper
• The impact of oral rehabilitation on oral health-related quality of life in patients receiving radiotherapy for the treatment of head and neck cancer

  2016cites this paper
• Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy

  2016cites this paper
• Olfaction in chemotherapy for head and neck malignancies.

  2016cites this paper
• Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: A pilot study

  2015cites this paper
• Radiotherapy induced xerostomia: mechanisms, diagnostics, prevention and treatment--evidence based up to 2013.

  2014cites this paper
• Role of perfusion computed tomography in assessing submandibular gland radiochemotherapy-induced injury.

  2014cites this paper
• Fehler und Gefahren: Medikamentöse und strahlentherapeutische Behandlung von Kopf-Hals-Malignomen

  2013cites this paper
• Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors

  2013influential citation
• The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT.

  2013cites this paper
• Hazards and risks in oncology: radiation oncology

  2013cites this paper
• Feasibility of image-guided radiotherapy based on helical tomotherapy to reduce contralateral parotid dose in head and neck cancer

  2012cites this paper
• Influence of intensity‐modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity‐modulated radiation therapy for nasopharyngeal cancer

  2012cites this paper
• Amifostine in the treatment of head and neck cancer: intravenous administration, subcutaneous administration, or none of the above.

  2011cites this paper
• Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapy

  2011cites this paper
• Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers

  2010cites this paper